IT

Integer Holdings Corporation

ITGRHealthcareNASDAQ

Medical Devices

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$1.85B
+8.0% YoY
Net Income
$102.8M
-14.3% YoY
EBITDA
$292.4M
-6.0% YoY
Free Cash Flow
$107.7M

Scan Results

Daily timeframe
2 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20▼ RSI OverboughtRSI 79.2, above 70, stock may be overbought
Oct 19▼ RSI OverboughtRSI 72.2, above 70, stock may be overbought
About Integer Holdings Corporation

Part of the healthcare sector, Integer Holdings Corporation (ITGR) is listed under Medical Devices. The $4.30B market capitalization puts ITGR squarely in mid-cap range for its industry. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.

Where ITGR stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, ITGR finished 22.58% above its 150-day moving average ($103.40) and 28.30% above its 200-day moving average ($98.79). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is ITGR overbought or oversold?

At the October 20, 2026 close, ITGR's RSI(14) was 79.2, in overbought territory (above 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$4.30B
P/E (TTM)34.57
Fwd P/E18.42
EPS$3.66
Beta0.58
52W Change+80.3%
Dividend Yield0.00%
ROE7.5%
Analysis

Integer Holdings Corporation carries $1.36B in total debt against $21.4M in cash reserves — debt is roughly 63.8x the cash position. Managing this leverage effectively will be important for long-term financial stability. Annual free cash flow of $107.7M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 7.5% points to modest capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 3.9% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $1.33B (2022) to $1.85B (2025), reflecting a 39% increase over the period.

With a beta below 0.7, Integer Holdings Corporation typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Integer Holdings Corporation's trajectory.

Links
More Healthcare stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms